![]() | This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Elanco was spun off from Eli Lilly like a while ago...perhaps redirecting isn’t the best option anymore. CastAStone //(talk) 03:40, 8 March 2020 (UTC)
![]() | This edit request by an editor with a conflict of interest has now been answered. |
NOTE: I’m proposing the following edits for FleishmanHillard on behalf of Elanco. I’m a paid editor and aware of the COI guidelines. Please let me know of any questions or comments as you review. Thanks. Jon Gray ( talk) 19:55, 8 August 2023 (UTC)
History Section
Elanco's flea and tick collar, branded "Seresto," which was developed by Bayer Animal Health and acquired by Elanco in 2020 [1]…
On July 13, 2023, following a multi-year review, the EPA announced that they were unable to determine whether Seresto was the cause for reported animal deaths and that the collars met registration standards necessary to remain on the market for five years. [2] [3] [4] Elanco and the EPA also agreed to develop a program designed to enhance data collection for adverse event reports and continued annual enhanced reporting of Seresto adverse event data. [5]
The collars have not been registered for sale in Canada. [10] Jon Gray ( talk) 19:55, 8 August 2023 (UTC)
References
Seresto collars were developed by German pharmaceutical giant Bayer, but the company sold its Animal Health division, which includes the Seresto collar, to Elanco for $7.5 billion in 2020.
Elanco said a review by the EPA and the U.S. Food and Drug Administration found the collars met EPA standards for product registration.
The EPA, which worked with the Food and Drug Administration to conduct the analysis, said that they were unable to get enough information from data that Elanco submitted to determine whether Seresto played a role in most death reports.
The popular Seresto flea and tick collar will remain on the market, but with new mitigation measures, the U.S. Environmental Protection Agency announced on Thursday. The EPA announced the measures after a multi-year analysis of the collars' safety. The agency limited the approval of the collar to five years and required Elanco — the manufacturer of Seresto — to conduct enhanced reporting for adverse events, do additional outreach to the veterinary community and put new warnings on the product's label, among other changes.
The popular Seresto flea and tick collar will remain on the market, but with new mitigation measures, the U.S. Environmental Protection Agency announced on Thursday. The EPA announced the measures after a multi-year analysis of the collars' safety. The agency limited the approval of the collar to five years and required Elanco — the manufacturer of Seresto — to conduct enhanced reporting for adverse events, do additional outreach to the veterinary community and put new warnings on the product's label, among other changes.
In an August 10, 2016, conference call, Health Canada told the EPA that it would not register Seresto in Canada.
In an August 10, 2016, conference call, Health Canada told the EPA that it would not register Seresto in Canada.
![]() | This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Elanco was spun off from Eli Lilly like a while ago...perhaps redirecting isn’t the best option anymore. CastAStone //(talk) 03:40, 8 March 2020 (UTC)
![]() | This edit request by an editor with a conflict of interest has now been answered. |
NOTE: I’m proposing the following edits for FleishmanHillard on behalf of Elanco. I’m a paid editor and aware of the COI guidelines. Please let me know of any questions or comments as you review. Thanks. Jon Gray ( talk) 19:55, 8 August 2023 (UTC)
History Section
Elanco's flea and tick collar, branded "Seresto," which was developed by Bayer Animal Health and acquired by Elanco in 2020 [1]…
On July 13, 2023, following a multi-year review, the EPA announced that they were unable to determine whether Seresto was the cause for reported animal deaths and that the collars met registration standards necessary to remain on the market for five years. [2] [3] [4] Elanco and the EPA also agreed to develop a program designed to enhance data collection for adverse event reports and continued annual enhanced reporting of Seresto adverse event data. [5]
The collars have not been registered for sale in Canada. [10] Jon Gray ( talk) 19:55, 8 August 2023 (UTC)
References
Seresto collars were developed by German pharmaceutical giant Bayer, but the company sold its Animal Health division, which includes the Seresto collar, to Elanco for $7.5 billion in 2020.
Elanco said a review by the EPA and the U.S. Food and Drug Administration found the collars met EPA standards for product registration.
The EPA, which worked with the Food and Drug Administration to conduct the analysis, said that they were unable to get enough information from data that Elanco submitted to determine whether Seresto played a role in most death reports.
The popular Seresto flea and tick collar will remain on the market, but with new mitigation measures, the U.S. Environmental Protection Agency announced on Thursday. The EPA announced the measures after a multi-year analysis of the collars' safety. The agency limited the approval of the collar to five years and required Elanco — the manufacturer of Seresto — to conduct enhanced reporting for adverse events, do additional outreach to the veterinary community and put new warnings on the product's label, among other changes.
The popular Seresto flea and tick collar will remain on the market, but with new mitigation measures, the U.S. Environmental Protection Agency announced on Thursday. The EPA announced the measures after a multi-year analysis of the collars' safety. The agency limited the approval of the collar to five years and required Elanco — the manufacturer of Seresto — to conduct enhanced reporting for adverse events, do additional outreach to the veterinary community and put new warnings on the product's label, among other changes.
In an August 10, 2016, conference call, Health Canada told the EPA that it would not register Seresto in Canada.
In an August 10, 2016, conference call, Health Canada told the EPA that it would not register Seresto in Canada.